JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB253237

Anti-Yellow Fever Virus NS1 antibody [HH7.B.D10.B8]

Be the first to review this product! 리뷰 제출

|

(1 출판물)

Mouse Monoclonal POLG antibody. Carrier free. Suitable for ELISA and reacts with Yellow fever virus samples. Cited in 1 publication.

대체 명칭 보기

Genome polyprotein

1 이미지
ELISA - Anti-Yellow Fever Virus NS1 antibody [HH7.B.D10.B8] (AB253237)
  • ELISA

Supplier Data

ELISA - Anti-Yellow Fever Virus NS1 antibody [HH7.B.D10.B8] (AB253237)

ELISA plates coated on bench overnight in 0.1M carbonate pH 9.6, 100 μl/well, washed once in wash buffer 300 μl/well (TBS + 0.1% tween 20) and blocked 2 hrs in 1% BSA in D-PBS 300 μl/well. Antibodies diluted to working strength in diluent (DPBS + 1% BSA + 0.05% Tween 20 + 0.2% Proclin 950). Added at 100 μl/well and incubated 2 hrs shaken at ambient temperature. Washed 3 x 300 μl/well. Goat anti Mouse IgG-HRP diluted 1/2500 in diluent, added at 100 μl/well and incubated with shaking 1 hr at ambient. Plate washed 6X300 μl/well. TMB added at 100 μl/well. Reaction for screening assay stopped by addition of 1M HCl 100 μl/well.

주요 정보

Host species

Mouse

Clonality

Monoclonal

Clone number

HH7.B.D10.B8

Isotype

IgG1

Carrier free

Yes

Reacts with

Yellow fever virus

Applications

ELISA

applications

Specificity

This antibody is specific for the NS1 protein of Yellow Fever virus, and does not cross-react with NS1 from other flaviviruses, including Dengue virus serotypes 1- 4, Zika virus, West Nile virus and Japanese Encephalitis virus. No cross-reactivity is seen with Chikungunya virus E1, E2 or C proteins.

Reactivity 정보

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ELISA" : {"fullname" : "ELISA", "shortname":"ELISA"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Yellow fever virus": { "ELISA-species-checked": "testedAndGuaranteed", "ELISA-species-dilution-info": "", "ELISA-species-notes": "<p>Antigens at 0.5 μg/ml and antibodies at 0.01 μg/ml.</p>" } } }

특성 및 보관 정보

제형
Liquid
Purification 테크닉
Affinity purification Protein G
Purification 관련 사항
Purified from tissue culture supernatant.
보관 버퍼
pH: 7 - 8 Constituents: PBS
배송 시 보관 조건
Blue Ice
적절한 단기 보관 기간
1-2 weeks
적절한 단기 보관 조건
+4°C
적절한 장기 보관 조건
-20°C
분주 정보
Upon delivery aliquot
보관 정보
Avoid freeze / thaw cycle

추가 정보

This supplementary information is collated from multiple sources and compiled automatically.

Yellow Fever Virus NS1 also known as Non-structural Protein 1 plays an important mechanical role in the viral lifecycle of yellow fever virus. This protein is approximately 46 kDa in size and is mainly expressed within the cytoplasm and secreted outside of infected host cells. NS1 assists in various aspects of virus replication and immune evasion particularly through its involvement in the formation of the viral replication complex. The secreted form of NS1 gets actively released from infected cells contributing to immune system modulation.
Biological function summary

The Non-structural Protein 1 promotes viral infection and survival. It facilitates viral replication by contributing to the formation of the replication organelle within the host cell. NS1 also interacts with host immune components hindering effective immune response. Although it is not part of a larger viral complex NS1 works synergistically with other non-structural proteins of yellow fever virus such as NS3 to enhance replication efficiency and immune evasion capabilities.

Pathways

Yellow Fever Virus NS1 is deeply implicated in viral replication and immune evasion mechanisms. In the viral replication pathway it aids the virus in establishing replication sites and stabilizing the viral replication machinery. Its interaction with the host immune signaling pathway interferes with the activation of the host immune response enabling the virus to persist. NS1 is intricately linked to other proteins such as NS4B in the viral replication machinery and indirectly supports immune evasion through these pathways.

Yellow Fever Virus NS1 contributes significantly to the pathogenicity of yellow fever a serious viral hemorrhagic disease. The protein plays a role in the development of the severe systemic symptoms associated with yellow fever infection by evading host immune detection which leads to liver damage and multi-organ failure. NS1 may influence the virulence of the virus by modulating the host's immune response and its interaction with host proteins can exacerbate disease outcomes. Understanding the mechanisms of NS1 could inform strategies for therapeutics and vaccine development for yellow fever.

제품 프로토콜

For this product, it's our understanding that no specific protocols are required. You can visit:

타겟 정보

Capsid protein C. Capsid protein C self-assembles to form an icosahedral capsid about 30 nm in diameter. The capsid encapsulates the genomic RNA (Probable). Plays a role in virus budding by binding to the cell membrane and gathering the viral RNA into a nucleocapsid that forms the core of a mature virus particle. During virus entry, may induce genome penetration into the host cytoplasm after hemifusion induced by the surface proteins. Can migrate to the cell nucleus where it modulates host functions.. Capsid protein C. Inhibits RNA silencing by interfering with host Dicer.. Peptide pr. Prevents premature fusion activity of envelope proteins in trans-Golgi by binding to envelope protein E at pH6.0. After virion release in extracellular space, gets dissociated from E dimers.. Protein prM. Acts as a chaperone for envelope protein E during intracellular virion assembly by masking and inactivating envelope protein E fusion loop. prM is the only viral peptide matured by host furin in the trans-Golgi network probably to avoid catastrophic activation of the viral fusion activity in acidic Golgi compartment prior to virion release. prM-E cleavage is inefficient, and many virions are only partially matured. These uncleaved prM would play a role in immune evasion.. Small envelope protein M. May play a role in virus budding. Exerts cytotoxic effects by activating a mitochondrial apoptotic pathway through M ectodomain. May display a viroporin activity.. Envelope protein E. Type II fusion protein that binds to host cell surface receptor and mediates fusion between viral and cellular membranes (By similarity). The envelope protein E shifts from dimeric state to trimeric state to perform fusion with the host membrane (By similarity). The fusion loops of the three subunits come together to form a membrane-insertable tip containing aromatic residues (By similarity). Envelope protein is synthesized in the endoplasmic reticulum in the form of heterodimer with protein prM. They play a role in virion budding in the ER, and the newly formed immature particle is covered with 60 spikes composed of heterodimers of precursor prM and envelope protein E (By similarity). Envelope protein exposes a positively-charged pr-binding pocket at the E dimer interface, inducing (prM/E)2 dimer formation to generate smooth particles in the Golgi (By similarity). The virion is transported to the Golgi apparatus where the low pH causes dissociation of PrM-E heterodimers and formation of E homodimers (By similarity). prM-E cleavage is inefficient, and many virions are only partially matured. These uncleaved prM would play a role in immune evasion (By similarity). Pr is shed from the particle upon subsequent secretion into the extracellular environment, leaving an activated particle, prone to mediate acidic pH-triggered membrane fusion upon entry into a target cell (By similarity).. Non-structural protein 1. Involved in immune evasion, pathogenesis and viral replication. Once cleaved off the polyprotein, is targeted to three destinations : the viral replication cycle, the plasma membrane and the extracellular compartment. Essential for viral replication. Required for formation of the replication complex and recruitment of other non-structural proteins to the ER-derived membrane structures. Excreted as a hexameric lipoparticle that plays a role against host immune response. Antagonizing the complement function. Binds to the host macrophages and dendritic cells. Inhibits signal transduction originating from Toll-like receptor 3 (TLR3).. Non-structural protein 2A. Component of the viral RNA replication complex that functions in virion assembly and antagonizes the host immune response.. Serine protease subunit NS2B. Required cofactor for the serine protease function of NS3. May have membrane-destabilizing activity and form viroporins (By similarity).. Serine protease NS3. Displays three enzymatic activities : serine protease, NTPase and RNA helicase. NS3 serine protease, in association with NS2B, performs its autocleavage and cleaves the polyprotein at dibasic sites in the cytoplasm : C-prM, NS2A-NS2B, NS2B-NS3, NS3-NS4A, NS4A-2K and NS4B-NS5. NS3 RNA helicase binds RNA and unwinds dsRNA in the 3' to 5' direction. Also plays a role in virus assembly (PubMed : 18199634).. Non-structural protein 4A. Regulates the ATPase activity of the NS3 helicase activity. NS4A allows NS3 helicase to conserve energy during unwinding.. Peptide 2k. Functions as a signal peptide for NS4B and is required for the interferon antagonism activity of the latter.. Non-structural protein 4B. Induces the formation of ER-derived membrane vesicles where the viral replication takes place. Inhibits interferon (IFN)-induced host STAT1 phosphorylation and nuclear translocation, thereby preventing the establishment of cellular antiviral state by blocking the IFN-alpha/beta pathway (PubMed : 15956546).. RNA-directed RNA polymerase/Methyltransferase NS5. Replicates the viral (+) and (-) RNA genome, and performs the capping of genomes in the cytoplasm (PubMed : 19850911). NS5 methylates viral RNA cap at guanine N-7 and ribose 2'-O positions (PubMed : 19850911). Besides its role in RNA genome replication, also prevents the establishment of cellular antiviral state by blocking the interferon-alpha/beta (IFN-alpha/beta) signaling pathway (PubMed : 25211074). IFN-I induces binding of NS5 to host IFN-activated transcription factor STAT2, preventing its transcriptional activity. Host TRIM23 is the E3 ligase that interacts with and polyubiquitinates NS5 to promote its binding to STAT2 and trigger IFN-I signaling inhibition (PubMed : 25211074).
See full target information Genome polyprotein

제품이 사용된 논문 (1)

Recent publications for all applications. Explore the 전체 목록 and refine your search

PeerJ 13:e19215 PubMed40183048

2025

Temporal and spatial distribution of histone acetylation in mouse molar development.

Applications

Unspecified application

Species

Unspecified reactive species

Wen Du,Wanyi Luo,Liwei Zheng,Xuedong Zhou,Wei Du
제품이 사용된 논문 모두 보기

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.
자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com